Pages that link to "Q41262422"
Jump to navigation
Jump to search
The following pages link to Liposomal doxorubicin (Q41262422):
Displaying 50 items.
- Cardiotoxicity in childhood cancer survivors: strategies for prevention and management (Q24628695) (← links)
- Pharmacokinetics, brain delivery, and efficacy in brain tumor-bearing mice of glutathione pegylated liposomal doxorubicin (2B3-101) (Q27300391) (← links)
- Simultaneous analysis of liposomal doxorubicin and doxorubicin using capillary electrophoresis and laser induced fluorescence (Q33485640) (← links)
- Antibacterial Efficacy against an In Vivo Salmonella typhimurium Infection Model and Pharmacokinetics of a Liposomal Ciprofloxacin Formulation (Q33690455) (← links)
- Anti-tumor efficacy of polymer–platinum(II) complex micelles fabricated from folate conjugated PEG-graft-α,β-poly [(N-amino acidyl)-aspartamide] and cis-dichlorodiammine platinum(II) in tumor-bearing mice (Q33855180) (← links)
- A comparison of liposomal formulations of doxorubicin with drug administered in free form: changing toxicity profiles (Q34458534) (← links)
- Efficacy of CPX-351, (cytarabine:daunorubicin) liposome injection, against acute lymphoblastic leukemia (ALL) xenograft models of the Pediatric Preclinical Testing Program (Q34543909) (← links)
- Folate receptor-targeted liposomes as vectors for therapeutic agents (Q35000511) (← links)
- Minimising the long-term adverse effects of childhood leukaemia therapy (Q35009418) (← links)
- Myocet (liposome-encapsulated doxorubicin citrate): a new approach in breast cancer therapy (Q35020538) (← links)
- Cardiac profiles of liposomal anthracyclines: greater cardiac safety versus conventional doxorubicin? (Q35771142) (← links)
- Peptide-modified liposomes for selective targeting of bombesin receptors overexpressed by cancer cells: a potential theranostic agent (Q35972562) (← links)
- Using breast cancer cell CXCR4 surface expression to predict liposome binding and cytotoxicity (Q36332186) (← links)
- Nanospheres encapsulating anti-leishmanial drugs for their specific macrophage targeting, reduced toxicity, and deliberate intracellular release (Q36378915) (← links)
- Role of calcium in gene delivery (Q36409049) (← links)
- Tumor microvascular permeability is a key determinant for antivascular effects of doxorubicin encapsulated in a temperature sensitive liposome (Q36959221) (← links)
- Anthracycline-induced cardiotoxicity and the cardiac-sparing effect of liposomal formulation (Q37059896) (← links)
- Anthracycline cardiotoxicity in childhood. (Q37165394) (← links)
- Enhanced tumor delivery and antitumor response of doxorubicin-loaded albumin nanoparticles formulated based on a Schiff base (Q37187692) (← links)
- DAFODIL: A novel liposome-encapsulated synergistic combination of doxorubicin and 5FU for low dose chemotherapy (Q37621452) (← links)
- Recent advances in intravenous delivery of poorly water-soluble compounds (Q37639306) (← links)
- Polymeric micelles as a new drug carrier system and their required considerations for clinical trials (Q37679942) (← links)
- Boron lipid-based liposomal boron delivery system for neutron capture therapy: recent development and future perspective (Q38101626) (← links)
- pH sensitive coiled coils: a strategy for enhanced liposomal drug delivery (Q38794157) (← links)
- Late Cardiotoxicity: Issues for Childhood Cancer Survivors (Q38845457) (← links)
- Modulation of induced cytotoxicity of doxorubicin by using apoferritin and liposomal cages (Q38928086) (← links)
- Spermidinium closo-dodecaborate-encapsulating liposomes as efficient boron delivery vehicles for neutron capture therapy (Q38960391) (← links)
- Cell penetrating peptide amphiphile integrated liposomal systems for enhanced delivery of anticancer drugs to tumor cells. (Q39219757) (← links)
- Lipid-peptide vesicle nanoscale hybrids for triggered drug release by mild hyperthermia in vitro and in vivo. (Q39303502) (← links)
- Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug (Q39653805) (← links)
- Liposome armed with herpes virus-derived gH625 peptide to overcome doxorubicin resistance in lung adenocarcinoma cell lines (Q39996592) (← links)
- Biochemical characterization of the interactions between doxorubicin and lipidic GM1 micelles with or without paclitaxel loading. (Q40568410) (← links)
- In ovo delivery of DNA to the avian embryo (Q40673815) (← links)
- Evaluation of doxorubicin toxicity on cardiomyocytes using a dual functional extracellular biochip (Q42928631) (← links)
- Cisplatin-loaded polymer-metal complex micelle with time-modulated decaying property as a novel drug delivery system (Q43702217) (← links)
- Drug-drug interactions arising from the use of liposomal vincristine in combination with other anticancer drugs (Q43781867) (← links)
- Process design for efficient and controlled drug incorporation into polymeric micelle carrier systems (Q43842898) (← links)
- Evaluation of selected antitumor agents as subversive substrate and potential inhibitor of trypanothione reductase: an alternative approach for chemotherapy of Leishmaniasis (Q43857951) (← links)
- Octreotide labeled aggregates containing platinum complexes as nanovectors for drug delivery. (Q44374131) (← links)
- Clickable functionalization of liposomes with the gH625 peptide from Herpes simplex virus type I for intracellular drug delivery (Q45362938) (← links)
- Development of nanocapsules bearing doxorubicin for macrophage targeting through the phosphatidylserine ligand: a system for intervention in visceral leishmaniasis (Q45836305) (← links)
- Efficient encapsulation of DNA plasmids in small neutral liposomes induced by ethanol and calcium (Q45871322) (← links)
- Encapsulation of bilayer vesicles by self-assembly (Q46185456) (← links)
- Incorporation of water-insoluble anticancer drug into polymeric micelles and control of their particle size (Q47278868) (← links)
- Transmembrane pH-driven Na permeability of fluorinated phospholipid-based membranes (Q47758808) (← links)
- Topical delivery of TRPsiRNA-loaded solid lipid nanoparticles confer reduced pain sensation via TRPV1 silencing, in rats. (Q47965414) (← links)
- Advances in nano-delivery systems for doxorubicin: an updated insight. (Q50106753) (← links)
- Preparation, Characterization, and Biological Analysis of Liposomal Formulations of Vincristine (Q56456249) (← links)
- Preparation and characterization of thermally responsive block copolymer micelles comprising poly(N-isopropylacrylamide-b-DL-lactide) (Q57189111) (← links)
- Stability of association of 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine with liposomes is composition dependent (Q73881339) (← links)